Any process that modulates the mass, volume, or shape of a cell.

intermediate filament cytoskeleton organization and biogenesis

intermediate filament cytoskeleton organisation and biogenesis

The assembly and arrangement of cytoskeletal structures comprising intermediate filaments and their associated proteins.

cellular morphogenesis during vegetative growth

The change in form (cell shape and size) that occurs during the development of a cell as it progresses through a mitotic cell cycle when it is not undergoing terminal differentiation.

The change in form (cell shape and size) that occurs when relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history.

Catalysis of the reaction: 3,4-dihydroxy-2-butanone 4-phosphate + 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione = 6,7-dimethyl-8-ribityllumazine + phosphate.

Catalysis of the reaction: sulfonate + 2-oxoglutarate + O2 = SO3(2-) (sulfite) + aminoacetaldehyde + succinate + CO2.

Control of the spatial distribution of intermediate filaments; includes organizing filaments into meshworks, bundles, or other structures, as by cross-linking.

Any process that modulates the frequency, rate, or extent of the breakdown of lipids into simpler components.

negative regulation of lipid degradation

Any process that stops, prevents or reduces the rate, frequency or extent of the breakdown of lipids into simpler components.

Interacting selectively with the enzyme nitric-oxide synthase.

regulation of nitric-oxide synthase activity

Any process that modulates the activity of the enzyme nitric-oxide synthase.

Catalysis of the reaction: D-arabinose + NAD(P)+ = D-arabinono-1,4-lactone + NAD(P)H + H+. Also acts on L-galactose, 6-deoxy- and 3,6-dideoxy-L-galactose.

nuclear mRNA cis splicing, via U2-type spliceosome

The joining together, after removal of an intervening sequence composed of one or more introns, of two segments of the same RNA molecule via U2-type spliceosomal catalysis to produce an mRNA composed only of exon sequences that all came from the same primary transcript.